Ever since the U.S. government has taken steps to protect and encourage research involving pathogens that could be used as biological weapons, that research has become much less efficient, according to a new analysis.
Though funding for research on so-called "select agents," or pathogens that can be used as weapons, has shot through the roof, and the number of papers using those organisms has risen in recent years, the work has become up to five times less efficient -- meaning, the same amount of funding produces fewer papers than it did before. "The price of the research was multiplied by maybe a factor of 5 for anthrax and maybe a factor of 2 for Ebola," said Carnegie Mellon University associate professor linkurl:Elizabeth Casman,;http://www.epp.cmu.edu/people/bios/casman.html who led an linkurl:analysis;http://www.pnas.org/cgi/doi/10.1073/pnas.0915002107 of the select agent literature that is published in this week's issue of the __Proceedings of the National Academy of...
Interested in reading more?
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!